{%languageSelectorLabel%}
{%activeLanguage%}This website is for UK Healthcare Professionals only
This promotional material is intended for UK Healthcare Professionals experienced in the diagnosis and treatment of psoriasis and psoriatic arthritis. SKYRIZI®▼(risankizumab) and adalimumab prescribing information & adverse event reporting information can be found below.
UK-RISN-230338. Date of preparation January 2024.
Please complete the form below and a member of the SKYRIZI team will get back to you.
Please fill in your details below only if you are a UK registered healthcare professional and would like to request a meeting with an AbbVie representative.
UK-SKZD-230205. Date of Preparation: November 2023
To direct you to the most appropriate information, please confirm:
I am a UK Healthcare Professional.
This AbbVie website is intended for UK Healthcare Professionals only and contains promotional content.
I am a member of the public based in the UK
Report adverse events (healthcare professionals in the UK)
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk or via the MHRA Yellow Card app, available in the Google Play or Apple App Stores.
Adverse events should also be reported to AbbVie at [email protected]
Reporting of side effects (patients and public in the UK)
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk or via the MHRA Yellow Card app, available in the Google Play or Apple App Stores. Adverse events should also be reported to AbbVie at [email protected]
By reporting side effects you can help provide more information on the safety of this medicine.
For medicines with black triangle:
▼ means the medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See https://yellowcard.mhra.gov.uk for how to report side effects or via the MHRA Yellow Card app, available in the Google Play or Apple App Stores. Adverse events should also be reported to AbbVie at [email protected]
UK-ABBV-230223. Date of preparation: June 2023